Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04747314 · ClinicalTrials.gov registry record · Phase 2
Treating Negative Affect in Low Back Pain Patients
A Phase 2 study of Chronic Low Back Pain and Negative Affectivity, sponsored by Ajay Wasan, MD, Msc.
- Completed
- Registry status
- Phase 2
- Development phase
- 308
- Enrollment target
- 3
- Study locations
NCT04747314 is a Phase 2 study of Chronic Low Back Pain and Negative Affectivity that has completed, run by Ajay Wasan, MD, Msc. The registered enrollment target is 308 participants, below the 588-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (48% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT04747314, a Phase 2 study of Chronic Low Back Pain and Negative Affectivity, has completed, sponsored by Ajay Wasan, MD, Msc.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 308 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study will examine how the use of antidepressant, physical therapy, and combination of both affects pain, function, and depression outcomes in chronic low back pain patients.
Conditions Studied
Interventions
- DRUG Antidepressant
- OTHER Enhanced Fear Avoidance Rehabilitation
Study Locations (3)
Massachusetts
- BWH Pain Management Center - Chestnut Hill
Minnesota
- Mayo Clinic - Rochester
Pennsylvania
- UPMC Pain Medicine At Centre Commons - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 308 participants |
| Start Date | 2021-03-31 |
| Est. Completion | 2024-12-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04747314
The ClinicalTrials.gov registry entry for NCT04747314 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 308 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 588-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (48% lower). The listed sponsor is Ajay Wasan, MD, Msc, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which Antidepressant is the first listed.
NCT04747314 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, Minnesota, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04747314 about?
NCT04747314 is a clinical study titled "Treating Negative Affect in Low Back Pain Patients". This study will examine how the use of antidepressant, physical therapy, and combination of both affects pain, function, and depression outcomes in chronic low back pain patients.
What is the current status of trial NCT04747314?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 308 participants. The study started on 2021-03-31. Estimated completion is 2024-12-20.
What conditions does trial NCT04747314 study?
This clinical trial studies the following conditions: Chronic Low Back Pain, Negative Affectivity.
What interventions are being tested in trial NCT04747314?
The interventions under investigation include: Antidepressant (DRUG), Enhanced Fear Avoidance Rehabilitation (OTHER).
Who is sponsoring clinical trial NCT04747314?
This trial is sponsored by Ajay Wasan, MD, Msc, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04747314 being conducted?
This trial has 3 study locations across Massachusetts, Minnesota, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression
RECRUITING · Phase 2
-
Modulation Effect of tACS on Chronic Low Back Pain
RECRUITING · Phase 2
-
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
RECRUITING · Phase 2
-
Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure
ACTIVE NOT RECRUITING · Phase 2
-
Low-Dose Naltrexone and Acetaminophen Combination in the Treatment of Chronic Low Back Pain (ANODYNE-4)
COMPLETED · Phase 2
-
Chronic Low Back Pain Research Project
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.